Sorry – wrong addressee [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2024-07-24 15:31 (52 d 07:21 ago) – Posting: # 24099
Views: 1,050

Hi QA,

❝ ❝ IMHO, such a product is a mere marketing gimmick.❝

❝ Thank you for your HO. Let the BD and marketing team take the call.

Sure. At the end of the day the ‘Guy in the Armani suit’ decides.

❝ Allow me to ask the same question. As a strategy to register this product in EU, what is your suggestion?

I’m not the best person to support something that I cannot scientifically defend.
To give you an example: I was once asked by an innovator to develop the concept for a modified (i.e., prolonged) release formulation of a drug with a half-life of > 48 hours, which is only administered chronically. Doesn’t make any sense – a clear case of evergreening. BE of MR is much more difficult than the one of IR.
Not my circus, not my monkeys. I refused.
🙈 🙉 🙊
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,225 posts in 4,879 threads, 1,652 registered users;
42 visitors (0 registered, 42 guests [including 8 identified bots]).
Forum time: 22:53 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5